tiprankstipranks
Cell Source Inc (CLCS)
OTHER OTC:CLCS
US Market

Cell Source (CLCS) Financial Statements

6 Followers

Cell Source Financial Overview

Cell Source's market cap is currently ―. The company's EPS TTM is $-0.183; its P/E ratio is -2.17; Cell Source is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -480.88K$ -497.96K$ -1.08M-$ -1.04M
EBITDA--$ -936.80K-$ -1.02M
Net Income Common Stockholders$ -1.65M$ -1.54M$ -1.99M-$ -1.55M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.58K$ 21.99K$ 133.01K$ 222.66K$ 65.94K
Total Assets$ 248.36K$ 362.33K$ 232.42K$ 409.85K$ 360.61K
Total Debt$ 130.04K$ 321.50K$ 0.00$ 1.83M$ 1.62M
Net Debt$ 127.46K$ 299.51K$ -133.01K$ 1.60M$ 1.55M
Total Liabilities$ 16.28M$ 15.31M$ 14.45M$ 13.04M$ 12.31M
Stockholders Equity$ -16.03M$ -14.95M$ -14.22M$ -12.63M$ -11.95M
Cash Flow-
Free Cash Flow--$ -310.05K-$ -1.09M
Operating Cash Flow$ -279.60K$ -1.04M$ -310.05K-$ -1.09M
Investing Cash Flow-----
Financing Cash Flow$ 260.56K$ 925.00K$ 219.96K-$ 1.15M
Currency in USD

Cell Source Earnings and Revenue History

Cell Source Debt to Assets

Cell Source Cash Flow

Cell Source Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis